A discussion with Philippe Huot: the challenges of discovering novel therapies for the treatment of Parkinson's disease

Neurodegener Dis Manag. 2024;14(5):127-129. doi: 10.1080/17582024.2024.2389034. Epub 2024 Aug 19.

Author

Philippe Huot^{1

2

3}

Affiliations

¹ Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, Canada.
² Department of Neurology & Neurosurgery, McGill University, Montreal, QC, Canada.
³ Movement Disorder Clinic, Division of Neurology, Department of Neuroscience, McGill University Health Centre, Montreal, QC, Canada.

PMID: 39161200
PMCID: PMC11526725 (available on 2025-08-19)
DOI: 10.1080/17582024.2024.2389034

No abstract available

Keywords: Parkinson’s disease; alpha-synuclein; dyskinesia; glutamate; glycine; parkinsonism; psychosis.